Effects of an intensive lifestyle intervention program on portal hypertension in patients with cirrhosis and obesity: the SportDiet study

Berzigotti, Annalisa, Albillos, Agustín, Villanueva, Candid, Genescá, Joan, Ardevol, Alba, Augustín, Salvador, Calleja, Jose Luis, Bañares, Rafael, García‐Pagán, Juan Carlos, Mesonero, Francisco, Bosch, Jaime, on behalf of the Ciberehd SportDiet Collaborative Group·2017·Hepatology
DOI 10.1002/hep.28992

Cited by (333)

Items 101–200 of 333

  1. Key takeaways from the updated multidisciplinary European MASLD guidelines
    Paul Horn, Frank Tacke · 2025 · eGastroenterology
  2. Exercise Training for Liver Transplant Candidates
    Bandar Al-Judaibi, Ibrahim Alqalami, Michael Sai Lai Sey, Karim M. Qumosani, Nancy Howes, Lynne B. Sinclair, Natasha Chandok, Anas Hussam Eddin, Roberto Hernandez‐Alejandro, Paul Marotta et al. · 2019 · Transplantation Proceedings
  3. Compensated liver cirrhosis: Natural course and disease-modifying strategies
    Ramesh K. Kumar, Sudhir Kumar, Sabbu Surya Prakash · 2023 · World Journal of Methodology
  4. Specific issues concerning the management of patients on the waiting list and after liver transplantation
    Patrizia Burra, Edoardo Giovanni Giannini, Paolo Caraceni, Stefano Ginanni Corradini, Maria Grazia Rendina, Riccardo Volpes, Pierluigi Toniutto · 2018 · Liver International
  5. Nursing care for patients with cirrhosis
    Núria Fabrellas, Patrizia Künzler‐Heule, Amy E. Olofson, Kathryn Jack, Marta Carol · 2023 · Journal of Hepatology
  6. Management of diabetes mellitus in patients undergoing liver transplantation
    Valeria Grancini, Veronica Resi, Eva Palmieri, Giuseppe Pugliese, Emanuela Orsi · 2019 · Pharmacological Research
  7. Management of Diabetes in Candidates for Liver Transplantation and in Transplant Recipients
    Lucia Brodosi, Salvatore Petta, Maria Letizia Petroni, Giulio Marchesini, Maria Cristina Morelli · 2021 · Transplantation
  8. Nutrition as Therapy in Liver Disease.
    N. Shah, A. Barritt · 2022 · Clinical Therapeutics
  9. Sarcopenia and Frailty in Cirrhosis: Assessment and Management.
    C. Bunchorntavakul · 2023 · The Medical clinics of North America
  10. Nonalcoholic fatty liver disease and sarcopenia: Where do we stand?
    Mikolasevic, Ivana, Pavic, Tajana, Filipec Kanizaj, Tajana, Bender, Darija Vranesic, Domislovic, Viktor, Krznaric, Zeljko · 2020 · Canadian Journal of Gastroenterology and Hepatology
  11. Current challenges and future perspectives in treating patients with NAFLD-related cirrhosis
    Maxime Mallet, Cristina Alina Silaghi, Philippe Sultanik, Filoména Conti, Marika Rudler, Vlad Ratziu, Dominique Thabut, Raluca Pais · 2023 · Hepatology
  12. Exercise and physical activity in cirrhosis: opportunities or perils
    Annette Bellar, Nicole Welch, Srinivasan Dasarathy · 2020 · Journal of Applied Physiology
  13. Arresting frailty and sarcopenia in cirrhosis: Future prospects
    Hui‐Wei Chen, Michael A. Dunn · 2018 · Clinical Liver Disease
  14. Updated S2k clinical practice guideline on non-alcoholic fatty liver disease (NAFLD) issued by the German society of gastroenterology, digestive and metabolic diseases (DGVS)–April 2022–AWMF Registration No.: 021–025
    Authors, Collaborators: · 2022 · Zeitschrift für Gastroenterologie
  15. Sarcopenia in Liver Transplantation
    John Richard Montgomery, Michael J. Englesbe · 2019 · Current Transplantation Reports
  16. Impact of HSD17B13 rs72613567 genotype on hepatic decompensation and mortality in patients with portal hypertension
    Bernhard Scheiner, Albert Friedrich Stättermayer, Philipp Schwabl, Theresa Bucsics, Rafael Paternostro, David Josef Maria Bauer, Benedikt Simbrunner, Ralf L. J. Schmidt, Rodrig Marculescu, Arnulf Ferlitsch et al. · 2019 · Liver International
  17. Mechanisms and implications of recompensation in cirrhosis
    Salvatore Silvio Piano, Thomas Reiberger, Jaime Bosch · 2024 · JHEP Reports
  18. The role of bariatric surgery in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
    Daniel Shouhed, Justin A. Steggerda, Miguel A. Burch, Mazen Noureddin · 2017 · Expert Review of Gastroenterology & Hepatology
  19. Advances in therapeutic options for portal hypertension
    Marina Vilaseca, Sergi Guixé‐Muntet, Anabel Fernández‐Iglesias, Jordi Gracia‐Sancho · 2018 · Therapeutic Advances in Gastroenterology
  20. Anthropometric measures associated with sarcopenia in outpatients with liver cirrhosis.
    L. A. A. Santos, T. Lima, M. Ietsugu, H. R. de Carvalho Nunes, X. Qi, F. Romeiro · 2019 · Nutrition & Dietetics
  21. ACG Clinical Guideline: Hepatic Encephalopathy
    Jasmohan Singh Bajaj, Simona Jakab, Arun B. Jesudian, Robert S. Rahimi, Andrés Duarte‐Rojo, Po-Hung Chen, Robert J. Wong, Elliot B. Tapper, Puneeta Tandon · 2026 · The American Journal of Gastroenterology
  22. Exercise physiology in cirrhosis and the potential benefits of exercise interventions: A review
    Jack West, Paul John Gow, Adam Testro, Brooke Chapman, Marie J. Sinclair · 2021 · Journal of Gastroenterology and Hepatology
  23. Focus on Semaglutide 2.4 mg/week for the Treatment of Metabolic Dysfunction‐Associated Steatohepatitis
    Salvatore Petta, KyeongJin Kim, Giovanni Targher, Stefano Romeo, Silvia C. Sookoian, Ming‐Hua Zheng, Alessio Aghemo, Luca V. C. Valenti · 2025 · Liver International
  24. Prediction of Decompensation in Patients with Compensated Cirrhosis: Does Etiology Matter?
    Gennaro D’Amico, Giovanni Perricone · 2019 · Current Hepatology Reports
  25. Sarcopenia in liver cirrhosis: Prevalence, pathophysiology and therapeutic strategies
    Rebecca Fox, Kate Stenning, Adrian Slee, Jane Macnaughtan, Nathan A. Davies · 2022 · Analytical Biochemistry
  26. Establishing hepatic decompensation as a meaningful clinical outcome during systemic therapy for hepatocellular carcinoma
    Giuseppe Cabibbo, Ciro Celsa, Sherrie Bhoori, Thomas Reiberger, David James Pinato, Calogero Cammà · 2025 · Journal of Hepatology
  27. Novel therapeutics for portal hypertension and fibrosis in chronic liver disease
    Sergi Guixé‐Muntet, Changpeng Zhu, Wei‐Fen Xie, Jordi Gracia‐Sancho · 2020 · Pharmacology & Therapeutics
  28. Cancer and hepatic steatosis
    R. Paternostro, W. Sieghart, M. Trauner, M. Pinter · 2021 · ESMO Open
  29. Clinical Overview of Sarcopenia, Frailty, and Malnutrition in Patients With Liver Cirrhosis
    Alexander T Kusnik, Amulya Penmetsa, Farooq Chaudhary, Keerthi Renjith, Gopal A. Ramaraju, Marie A. Laryea, Johane P. Allard · 2024 · Gastroenterology Research
  30. Sport and Exercise in Improving Outcomes After Solid Organ Transplantation: Overview From a UK Meeting
    James Neuberger, Matthew James Armstrong, James P. Fisher, Patrick Barry Mark, Kelly Ann Schmidtke, Adnan Sharif, Ivo Vlaev · 2019 · Transplantation
  31. Treatment Options and Continuity of Care in Metabolic-associated Fatty Liver Disease: A Multidisciplinary Approach
    Carmen Lara, Manuel Romero‐Gómez · 2024 · European Cardiology Review
  32. Bile acid signaling in MASLD: From pathogenesis to therapeutic applications
    Benedikt Simbrunner, Rafael Paternostro, Thomas Reiberger, Michael Trauner · 2025 · Hepatology
  33. The role of prehabilitation on short‐term outcomes after liver transplantation: A review of the literature and expert panel recommendations
    Carmen Vinaixa, Graciela Martínez‐Palli, Don Milliken, Daniel Sellers, Sébastien Dharancy, Michael D. Spiro, Dimitri Aristotle Raptis, Didier Samuel, the ERAS4OLT.org Working Group · 2022 · Clinical Transplantation
  34. Managing cirrhosis with limited resources: perspectives from sub-Saharan Africa
    Mark Wayne Sonderup, Patrick S. Kamath, Yaw Asante Awuku, Hailemichael Desalegn, Neliswa A. Gogela, Leolin Katsidzira, Christian Tzeuton, Bilal Bobat, Chris Kassianides, C Wendy Spearman · 2024 · The Lancet. Gastroenterology & hepatology
  35. The Association of Hispanic Ethnicity with Nonalcoholic Fatty Liver Disease in Polycystic Ovary Syndrome
    Monika A. Sarkar, Norah A. Terrault, Caroline C. Duwaerts, Phyllis C. Tien, Marcelle Ivonne Cedars, Heather Gibson Huddleston · 2018 · Current Opinion in Gynecology and Obstetrics
  36. Exercise prescription in patients with cirrhosis: Recommendations for clinical practice
    Ricardo Ulises Macías‐Rodríguez, Astrid Ruiz‐Margáin, Berenice Monserrat Román-Calleja, E. Moreno-Tavarez, L. Weber-Sangri, M.F. González-Arellano, G. Fernández-del-Rivero, K. Ramírez-Soto · 2019 · Revista de Gastroenterología de México (English Edition)
  37. Management of Lifestyle Factors in Individuals with Cirrhosis: A Pragmatic Review
    Puneeta Tandon, Annalisa Berzigotti · 2019 · Seminars in Liver Disease
  38. Emerging Therapeutic Targets for Portal Hypertension
    Éric Felli, Yelidousi Nulan, Sonia Emilia Selicean, Cong Wang, Jordi Gracia‐Sancho, Jaime Bosch · 2023 · Current Hepatology Reports
  39. Effect of branched-chain amino acid supplementation and exercise on quadriceps muscle quantity and quality in patients with cirrhosis as assessed by ultrasonography: A randomized controlled trial
    Elham Sobhy, Mohamed Mahmoud Kamal, Yasmin Saad, Doaa Ahmed Saleh, Rasmia Elgohary, Mohamed Sayed Hassan · 2024 · Clinical Nutrition ESPEN
  40. Portal Hypertension and Ascites: Patient-and Population-centered Clinical Practice Guidelines by the Italian Association for the Study of the Liver (AISF)
    Raffaele Bruno, Calogero Cammà, Paolo Caraceni, Gennaro D’Amico, Ignazio Grattagliano, Vincenzo La Mura, Oliviero Riggio, Filippo Schepis, Marco Senzolo, Paolo Angeli et al. · 2021 · Digestive and Liver Disease
  41. Telemedicine in Patients Affected by Chronic Liver Disease: A Scoping Review of Clinical Outcomes and the Devices Evaluated
    Paolo Capuano, Bethany Hileman, Stefano Tigano, Bianca Magro, Vincenzina Lo Re, Rosa Liotta, Marco Sciveres, Giusy Ranucci, Alessio Provenzani, Gaetano Burgio et al. · 2023 · Journal of Clinical Medicine
  42. Pharmacotherapy for Weight Loss in Cirrhosis and Liver Transplantation: Translating the Data and Underused Potential
    Sara Ann Brown, Manhal J. Izzy, Kymberly D. S. Watt · 2020 · Hepatology
  43. Voluntary distance running prevents TNF-mediated liver injury in mice through alterations of the intrahepatic immune milieu
    Yvonne Huber, Nadine Gehrke, Jana Biedenbach, Susanne Helmig, Perikles D. Simon, Beate Katharina Straub, Ina Bergheim, Tobias Huber, Detlef Schuppan, Peter R. Galle et al. · 2017 · Cell Death and Disease
  44. Portal Hypertension in Malnutrition and Sarcopenia in Decompensated Cirrhosis—Pathogenesis, Implications and Therapeutic Opportunities
    Ryma Terbah, Adam Testro, Paul John Gow, Avik Majumdar, Marie J. Sinclair · 2023 · Nutrients
  45. Physical exercise in liver diseases
    Yunwei Zhang, Chunyan Cao, Chaofan Li, Russell Gardner Witt, Hai Huang, Allan Tsung, Hongji Zhang · 2024 · Hepatology
  46. Sarcopenia in Liver Transplantation: an Update
    Amritpal Dhaliwal, Felicity Rhian Williams, Omar El‐Sherif, Matthew James Armstrong · 2020 · Current Hepatology Reports
  47. Impact of Liver and Pancreas Diseases on Nutritional Status
    Pablo Cañamares‐Orbís, Vanesa Bernal Monterde, Olivia Sierra Gabarda, Diego Casas Deza, Guillermo García‐Rayado, Luis Cortés, Alberto Luè · 2021 · Nutrients
  48. Obesity Management of Liver Transplant Waitlist Candidates and Recipients
    Danielle Brandman · 2020 · Clinics in Liver Disease
  49. The Influence of Irisin on Selected Organs—The Liver, Kidneys, and Lungs: The Role of Physical Exercise
    Maria Ciałowicz, Marek Woźniewski, Eugenia Murawska‐Ciałowicz, Piotr Dzięgiel · 2025 · Cells
  50. Diabetes impairs the haemodynamic response to non‐selective betablockers in compensated cirrhosis and predisposes to hepatic decompensation
    Rafael Paternostro, Mathias Jachs, Lukas Hartl, Benedikt Simbrunner, Bernhard Scheiner, David Josef Maria Bauer, Philipp Schwabl, Georg Semmler, Michael A Trauner, Mattias Mandorfer et al. · 2023 · Alimentary Pharmacology & Therapeutics
  51. Therapeutic Physical Exercise Programs in the Context of NASH Cirrhosis and Liver Transplantation: A Systematic Review
    Marwin A. Farrugia, Sébastien Le Garf, Andrea Piero Chierici, Thierry Piche, Philippe Gual, Antonio Iannelli, Rodolphe Anty · 2023 · Metabolites
  52. Patient and Caregiver Attitudes and Practices of Exercise in Candidates Listed for Liver Transplantation
    David M. H. Chascsa, Jennifer C. Lai, Michael A. Dunn, Aldo J. Montaño‐Loza, Matthew Robert Kappus, Srinivasan Dasarathy, Elizabeth J. Carey · 2018 · Digestive Diseases and Sciences
  53. Intragastric balloon in obese compensated nonalcoholic steatohepatitis cirrhosis patients is safe and achieves significant weight reduction at 6-months
    Vijayaraghavan, Rajan, Sarin, Shiv K., Bharadwaj, Ankit, Anand, Lovkesh, Maiwall, Rakhi, Choudhury, Ashok, Benjamin, Jaya, Kanal, Uma, Jamwal, Kapil Dev · 2023 · Digestive Diseases and Sciences
  54. Sarcopenia in end-stage liver disease and after liver transplantation
    Sofie Leunis, Marieke Vandecruys, Amaryllis H. Van Craenenbroeck, Véronique Cornelissen, Stijn Bogaerts, Stefan De Smet, Diethard R.L. Monbaliu · 2023 · Acta gastro-enterologica belgica
  55. S2k-Leitlinie Klinische Ernährung in der Hepatologie
    Mathias Plauth, Lars P. Bechmann, Donata Grajecki, Felix Gundling, Ludwig Kramer, Andreas Emanuel Kremer, Monika Rau, Andrea Schneider, Frank Tacke, Ingo van Thiel · 2024 · Aktuelle Ernährungsmedizin
  56. Prognostic role of computed tomography analysis using deep learning algorithm in patients with chronic hepatitis B viral infection
    Jeongin Yoo, Heejin Cho, Dong Ho Lee, Eun Ju Cho, Ijin Joo, Sun Kyung Jeon · 2023 · Clinical and Molecular Hepatology
  57. Bariatric surgery proves long-term benefit in patients with cirrhosis
    Manhal J. Izzy, Mounika Angirekula, Barham K. Abu Dayyeh, Fateh Bazerbachi, Kymberly D. S. Watt · 2020 · Gastroenterology report
  58. Role of Exercise in the Management of Hepatic Encephalopathy: Experience From Animal and Human Studies
    Luise Aamann, Puneeta Tandon, Chantal Bémeur · 2018 · Journal of Clinical and Experimental Hepatology
  59. Peri-transplant management of nonalcoholic fatty liver disease in liver transplant candidates
    Naga Swetha Samji, Rajiv Prakash Heda, Sanjaya Kumar Satapathy · 2019 · Translational Gastroenterology and Hepatology
  60. Liver disorders in COVID-19, nutritional approaches and the use of phytochemicals
    Nancy Vargas-Mendoza, Jazmín García‐Machorro, Marcelo Ángeles-Valencia, Marlet Martínez‐Archundia, Eduardo Madrigal‐Santillán, Ángel Morales‐González, Liliana Anguiano‐Robledo, José A. Morales‐González · 2021 · World Journal of Gastroenterology
  61. Sarcopenia in cirrhosis: epidemiology, diagnosis, management and prognosis
    Yi Liu, Fanpu Ji, Mindie H. Nguyen · 2023 · Current Opinion in Gastroenterology
  62. A review and critique of published real-world weight management program studies
    Craig Primack · 2018 · Postgraduate Medicine
  63. Steatosis as main determinant of portal hypertension through a restriction of hepatic sinusoidal area in a dietary rat nash model
    Aurora Barberá, Imma Raurell, Teresa García‐Lezana, Manuel Torres‐Arauz, Miren Bravo, Diana Hide, Mar Gil, María Teresa Salcedo, Joan Genescà, Marı́a Martell et al. · 2020 · Liver International
  64. Impact of Sex and Gender on Clinical Management of Patients with Advanced Chronic Liver Disease and Type 2 Diabetes
    Anna Licata, Giuseppina Tiziana Russo, Annalisa Giandalia, Marcella Cammilleri, Clelia Asero, Irene Cacciola · 2023 · Journal of Personalized Medicine
  65. The effect of endoscopic gastric plication on portosystemic pressure gradient in patients with nonalcoholic fatty liver disease and compensated advanced chronic liver disease
    Pichamol Jirapinyo, Christopher C. Thompson, Guadalupe García–Tsao, Stephen D. Zucker, Marvin K. Ryou · 2023 · Endoscopy
  66. Late-stage presentation with decompensated cirrhosis is alarmingly common but successful etiologic therapy allows for favorable clinical outcomes
    Michael Schwarz, Caroline Schwarz, Lukas Burghart, Nikolaus Pfisterer, David Josef Maria Bauer, Wolfgang Hübl, Mattias Mandorfer, Michael Gschwantler, Thomas Reiberger · 2023 · PLoS ONE
  67. Eating Patterns in Patients with Compensated Cirrhosis: A Case-Control Study
    Camille Buscail, Valérie Bourcier, Léopold Fezeu, Dominique M. Roulot, Séverine Brulé, Zahia Ben Abdesselam, Carole Cagnot, Serge Herçberg, Pierre Nahon, Nathalie Ganne‐Carrié et al. · 2018 · Nutrients
  68. Prescripción de ejercicio en pacientes con cirrosis: recomendaciones para la atención clínica
    Ricardo Ulises Macías‐Rodríguez, Astrid Ruiz‐Margáin, Berenice Monserrat Román-Calleja, E. Moreno-Tavarez, L. Weber-Sangri, M.F. González-Arellano, G. Fernández-del-Rivero, K. Ramírez-Soto · 2019 · Revista de Gastroenterología de México
  69. Frailty in liver transplantation: Exploring prescribing exercise as medicine to improve patient outcomes
    Sara J. Harris, Jonathan G. Stine · 2024 · Liver International
  70. Current and emerging therapies for alcohol-associated hepatitis
    Francisco Javier Idalsoaga, Gustavo Ayares, Luis Antonio Díaz, Jorge Arnold, María Ayala-Valverde, David Hudson, Marco A. Arrese, Juan Pablo Arab · 2023 · Liver Research
  71. Implementation of a randomized mobile-technology lifestyle program in individuals with nonalcoholic fatty liver disease
    Monica A. Tincopa, Nik Patel, Areesha Shahab, Haila Asefa, Anna Suk-Fong Lok · 2024 · Scientific Reports
  72. Preventing the progression of cirrhosis to decompensation and death
    Càndid Villanueva, Dhiraj Tripathi, Jaime Bosch · 2025 · Nature Reviews Gastroenterology & Hepatology
  73. Advances in the diagnosis and management of clinically significant portal hypertension in cirrhosis: A narrative review
    Xiaoyu Xie, Amine Benmassaoud · 2025 · World Journal of Hepatology
  74. Impact of visceral fat accumulation on the prognosis of patients with cirrhosis
    Yoji Ishizu, Masatoshi Ishigami, Takashi Honda, Norihiro Imai, Takanori Ito, Kenta Yamamoto, Mitsuhiro Fujishiro · 2021 · Clinical Nutrition ESPEN
  75. Improving Management of Portal Hypertension: The Potential Benefit of Non-Etiological Therapies in Cirrhosis
    Niccolò Bitto, Gabriele Ghigliazza, Stanislao Lavorato, Camilla Caputo, Vincenzo La Mura · 2023 · Journal of Clinical Medicine
  76. Rifaximin Alfa and Liver Diseases: More Than a Treatment for Encephalopathy, a Disease Modifier
    Aldo Torre, Jacqueline Córdova‐Gallardo, Alberto C. Frati Munari · 2023 · Therapeutics and Clinical Risk Management
  77. Evaluation of liver transplant candidates with non-alcoholic steatohepatitis
    James Phillip Esteban, Amon Asgharpour · 2021 · Translational Gastroenterology and Hepatology
  78. Obesity Primer for the Practicing Gastroenterologist
    Pichamol Jirapinyo, Christopher C. Thompson · 2021 · The American Journal of Gastroenterology
  79. Combination of Fat-Free Muscle Index and Total Spontaneous Portosystemic Shunt Area Identifies High-Risk Cirrhosis Patients
    Anton Faron, Jasmin Abu-Omar, Johannes Chang, Nina Böhling, Alois Martin Sprinkart, Ulrike Irmgard Attenberger, Jürgen Kurt Rockstroh, Andreas Minh Luu, Christian Jansen, Christian P. Strassburg et al. · 2022 · Frontiers in Medicine
  80. Effectiveness of an Interdisciplinary Program Performed on Obese People Regarding Nutritional Habits and Metabolic Comorbidity: A Randomized Controlled Clinical Trial
    Virginia Esperanza Fernández-Ruiz, Antonio Jesús Ramos‐Morcillo, María Solé-Agustí, José Antonio Paniagua‐Urbano, David Armero‐Barranco · 2020 · International Journal of Environmental Research and Public Health
  81. Nutritional and Psychological Support as a Multidisciplinary Coordinated Approach in the Management of Chronic Liver Disease: A Scoping Review
    Mario Romeo, Marcello Dallio, Marina Cipullo, Annachiara Coppola, Chiara Mazzarella, Simone Mammone, Giorgia Iadanza, Carmine Napolitano, Paolo Vaia, Lorenzo Ventriglia et al. · 2025 · Nutrition Reviews
  82. Short-Term Western Diet Aggravates Non-Alcoholic Fatty Liver Disease (NAFLD) With Portal Hypertension in TGR(mREN2)27 Rats
    Carla Cremonese, Robert Schierwagen, Frank Erhard Uschner, Sandra Torres, Olaf Tyc, Cristina Ortiz, Martin Sebastian Schulz, Alexander Queck, Glen Kristiansen, Michael Bäder et al. · 2020 · International Journal of Molecular Sciences
  83. Prevalence and Nonpharmacological Interventions for Sarcopenia among Cirrhotic Patients
    Walid Kamal Abdelbasset, Gopal S Nambi, Shereen Hamed ELSAYED, Samah Alsaid Ahmed Moawd, Ahmed Abdelmoniem Ibrahim, Anju Verma, Sayed A. Tantawy, Dalia M. Kamel, Ayman K. Saleh, Osama R. Aldhafian et al. · 2021 · Disease Markers
  84. Is Exercise Beneficial and Safe in Patients with Cirrhosis and Portal Hypertension?
    Elliot B. Tapper, Roberto F. Martínez-Macías, Andrés Duarte‐Rojo · 2018 · Current Hepatology Reports
  85. Performance of Controlled Attenuation Parameter in Patients with Advanced Chronic Liver Disease and Portal Hypertension
    Georg Semmler, Judith Stift, Bernhard Scheiner, Katharina Wöran, Philipp Schwabl, Rafael Paternostro, Theresa Bucsics, Albert Friedrich Stättermayer, Matthias Pinter, Arnulf Ferlitsch et al. · 2019 · Digestive Diseases and Sciences
  86. A randomized trial to promote physical activity in adult pre-hypertensive and hypertensive patients
    Yang Bai, Ryan D. Burns, Nancy Gell, Wonwoo Byun · 2022 · Journal of Sports Sciences
  87. Effect of a monitored exercise protocol in cerebral and hepatic hemodynamics in patients with cirrhosis and portal hypertension
    Ricardo Ulises Macías‐Rodríguez, Astrid Ruiz‐Margáin, Berenice Monserrat Román-Calleja, Carlos Gerardo Cantú-Brito, Fernando Flores-Silva, Alejandro Gabutti, Octavio Aguilar-Nájera, Mariana Cruz-Contreras, L. Weber-Sangri, Silvia L. Ríos-Torres et al. · 2023 · Digestive and Liver Disease
  88. MASH to cirrhosis: bridging the gaps in MASLD management
    Zouhir Gadi, Wilhelmus Josephus Kwanten, Luisa Vonghia, Sven Francque · 2024 · Acta Clinica Belgica
  89. Sleeve Gastrectomy Reversed Obesity-Induced Hypogonadism in a Rat Model by Regulating Inflammatory Responses in the Hypothalamus and Testis
    Jun Xiang, Cuidong Bian, Xiaodong Wan, Qimin Zhang, Shengsong Huang, Denglong Wu · 2018 · Obesity Surgery
  90. Dietary Interventions in Liver Diseases: Focus on MAFLD and Cirrhosis
    Élise Vuille‐Lessard, Naomi Franziska Lange, Carlotta Riebensahm, Jean‐François Dufour, Annalisa Berzigotti · 2021 · Current Hepatology Reports
  91. Exercise Interventions for Cirrhosis
    Élise Vuille‐Lessard, Annalisa Berzigotti · 2022 · Current Treatment Options in Gastroenterology
  92. Management and Risks Before, During, and After Liver Transplant in Individuals With Obesity.
    Saleh A. Alqahtan, Robert S. Brown · 2023 · PubMed Central
  93. Patients' Intensive Telephone-Based Care Program Reduces Depression in Coronary Artery Disease Patients and May Contribute to Favorable Overall Survival by Decreasing Depression
    Lan-Ju Yang, Xuemei Wang, Xiaoning Cui · 2019 · The Journal of Cardiovascular Nursing
  94. Peculiarities of Cirrhosis due to Nonalcoholic Steatohepatitis (NASH)
    Omar El‐Sherif, Matthew James Armstrong · 2019 · Seminars in Liver Disease
  95. Walking exercise through smartphone application plus branched-chain amino acid supplementation benefits skeletal muscle mass and strength in liver cirrhosis: A prospective control trial
    Qian Xiang, Jing Xiong, Zhi jing Zhao, Ting Zhou, Jun Wu, Xia Chen · 2023 · Zeitschrift für Gastroenterologie
  96. Optimal Management of Obesity in Transplant Candidates and Recipients
    Jenny Lam, Mohammad Qasim Khan, Kymberly D. S. Watt, Tayyab S. Diwan · 2024 · Current Transplantation Reports
  97. Impact of Weight Loss on Metabolic Dysfunction Associated Steatohepatitis and Hepatic Fibrosis
    Marina Takawy, Manal F. Abdelmalek · 2025 · Current Diabetes Reports
  98. Overweight/Obesity Increases the Risk of Overt Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt in Cirrhotic Patients
    Lihong Gu, Xiaochun Yin, Yang Cheng, Xixuan Wang, Ming Zhang, Xiaoping Zou, Lei Wang, Yuzheng Zhuge, Feng Zhang · 2023 · Journal of Personalized Medicine
  99. Impact of a lifestyle intervention program on cardio-metabolic parameters among obese adults: A comparative population-based study in West Bengal, India
    Alak Kumar Syamal, Chaitali Bose, AmolDilip Kinge, Julekha Sultana, Ajoy Kumar Biswas, Koushik Bhattacharya · 2023 · Journal of Medicine and Life
  100. Nutritional Evaluation and Treatment of the Cirrhotic Patient
    Shira Zelber‐Sagi, Dana Ivancovsky Wajcman, Liane Rabinowich, Itay Bentov, Liat Deutsch · 2021 · Clinics in Liver Disease